A Dose-range Study of the Safety and Efficacy of Treatment in Adult Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate
Clinical trial NCT05604885 · COMPLETED
Trial details
- NCT number
- NCT05604885
- Sponsor
- SynAct Pharma Aps
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-30
- Primary completion
- 2023-08-28
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.